CA3135976A1 - Salivary biomarkers for the detection of epidermoid cancer of the head and neck - Google Patents

Salivary biomarkers for the detection of epidermoid cancer of the head and neck Download PDF

Info

Publication number
CA3135976A1
CA3135976A1 CA3135976A CA3135976A CA3135976A1 CA 3135976 A1 CA3135976 A1 CA 3135976A1 CA 3135976 A CA3135976 A CA 3135976A CA 3135976 A CA3135976 A CA 3135976A CA 3135976 A1 CA3135976 A1 CA 3135976A1
Authority
CA
Canada
Prior art keywords
salivary
genus
cancer
bacteria belonging
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3135976A
Other languages
English (en)
French (fr)
Inventor
Vicente Manuel Navarro Lopez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionou Research SL
Original Assignee
Bionou Research SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionou Research SL filed Critical Bionou Research SL
Publication of CA3135976A1 publication Critical patent/CA3135976A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA3135976A 2019-04-05 2020-04-06 Salivary biomarkers for the detection of epidermoid cancer of the head and neck Pending CA3135976A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382253.3A EP3719498A1 (en) 2019-04-05 2019-04-05 Salivary biomarkers for the detection of head and neck epidermoid cancer (cecc)
EP19382253.3 2019-04-05
PCT/EP2020/059761 WO2020201575A1 (en) 2019-04-05 2020-04-06 Salivary biomarkers for the detection of epidermoid cancer of the head and neck

Publications (1)

Publication Number Publication Date
CA3135976A1 true CA3135976A1 (en) 2020-10-08

Family

ID=67437232

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3135976A Pending CA3135976A1 (en) 2019-04-05 2020-04-06 Salivary biomarkers for the detection of epidermoid cancer of the head and neck

Country Status (10)

Country Link
US (1) US12584178B2 (enExample)
EP (2) EP3719498A1 (enExample)
JP (1) JP7557789B2 (enExample)
KR (1) KR20210149144A (enExample)
CN (1) CN114008458A (enExample)
AU (1) AU2020252417B2 (enExample)
CA (1) CA3135976A1 (enExample)
ES (1) ES3053185T3 (enExample)
PL (1) PL3948285T3 (enExample)
WO (1) WO2020201575A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12334375B2 (en) 2019-08-08 2025-06-17 Lam Research Corporation Spindle assembly for wafer transfer in a multi-station process module
KR20240052707A (ko) * 2022-10-14 2024-04-23 국립암센터 구강 미생물총 기반 구강암의 진단

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10954571B2 (en) * 2016-06-23 2021-03-23 The Charlotte-Mecklenburg Hospital Authority Compositions and methods for oral microbiome signatures
KR101854523B1 (ko) * 2016-06-30 2018-05-04 연세대학교 산학협력단 폐암의 진단 또는 폐암의 병기에 관한 정보를 제공하는 방법 및 이를 이용하는 키트

Also Published As

Publication number Publication date
EP3948285C0 (en) 2025-09-03
US20220170111A1 (en) 2022-06-02
US12584178B2 (en) 2026-03-24
ES3053185T3 (en) 2026-01-20
AU2020252417B2 (en) 2025-12-18
EP3719498A1 (en) 2020-10-07
KR20210149144A (ko) 2021-12-08
EP3948285B1 (en) 2025-09-03
CN114008458A (zh) 2022-02-01
EP3948285A1 (en) 2022-02-09
WO2020201575A1 (en) 2020-10-08
JP7557789B2 (ja) 2024-09-30
AU2020252417A1 (en) 2021-12-02
PL3948285T3 (pl) 2025-12-01
JP2022529909A (ja) 2022-06-27

Similar Documents

Publication Publication Date Title
KR102930361B1 (ko) 암의 평가 및/또는 치료를 위한 무 세포 dna
KR20170053617A (ko) 폐암 상태를 평가하는 방법
KR102194215B1 (ko) 위암 진단용 바이오마커 및 이의 용도
AU2020252417B2 (en) Salivary biomarkers for the detection of epidermoid cancer of the head and neck
JP2020515264A (ja) 早期膵がんを診断するための方法およびキット
JP2021506308A (ja) 遺伝子発現プロファイルを使用して肺癌を診断するための組成物および方法
KR102627788B1 (ko) 위암 바이오마커 및 그 용도
CN114480636B (zh) 胆汁细菌作为肝门部胆管癌诊断及预后标志物的用途
CN118006815A (zh) 具核梭杆菌特异性dna序列及其应用和检测方法
KR102954588B1 (ko) 기관지폐포세척액의 마이크로바이옴을 포함하는 폐암 진단용 바이오마커 조성물
WO2022013880A1 (en) Blood based biomarkers for early diagnosis and follow up of breast cancer
WO2019095541A1 (zh) 一种诊断预示乳腺癌骨转移的组合物及诊断预示方法
CN116479152B (zh) 微生物标志物在制备头颈部鳞状细胞癌检测产品中的应用
JP7847450B2 (ja) アトピー性皮膚炎の症度悪化の検出方法
Qin et al. Noninvasive detection of early nasopharyngeal carcinoma based on three gene methylation analysis in bilateral nasal swab samples processed automatically
KR20240176856A (ko) 기관지폐포세척액의 마이크로바이옴을 포함하는 폐암 진단용 바이오마커 조성물
Axelsson et al. PD46-05 GENETIC ABERRATIONS IDENTIFIED IN FOCAL BARBOTAGES–a COMPLEMENTARY DIAGNOSTIC TOOL IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC)
Zhou et al. Houcong Liu1, 4, Loren Hansen2, 4, Changpu Song3, Haijiu Lin3, Dan Chen3, Zhufang Chen1
JP2023162781A (ja) 診断薬、薬効予測キット、薬効予測方法、及びマーカー
CN119685479A (zh) 用于胰腺癌早期诊断的sEV mRNA组合标志物、其应用及检测试剂盒
JP2026040607A (ja) アトピー性皮膚炎の重症度の検出方法
CN121802048A (zh) 一种结直肠癌诊断的新型生物标志物5’-tiRNA-Tyr的检测及应用
WO2022210783A1 (ja) 甲状腺濾胞癌特異的マーカー
CN119799888A (zh) 液体活检中短双链无细胞dna的定量分析
CN116219007A (zh) 检测结直肠癌的生物标志物组及其应用

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240314

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250218

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250401

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250401

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250616

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250616

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250623

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250623